Biotech

All Articles

TPG tops up funds to $580M for expenditures throughout lifestyle sciences

.Possession manager TPG, which has actually supported biotechs like Sionna Rehabs and also Santa Cla...

Merck stops stage 3 TIGIT test in lung cancer for impossibility

.Merck &amp Co.'s TIGIT system has endured an additional problem. Months after shuttering a stage 3 ...

After a tough year, Exscientia folds in to Recursion

.After a year defined by pipeline hairstyles, the shift of its CEO and also layoffs, Exscientia is g...

Cullinan, after $25M package, return bispecific to Port

.Cullinan Rehab was wowed sufficient along with Harbour BioMed's bispecific immune system reactor th...

A more detailed take a look at Fierce Biotech's Strong 15

.Within this full week's incident of "The Top Pipe," our company're diving in to Brutal Biotech's an...

Lilly faces stage 2 failing of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's event celebrating the commendation of Alzhe...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, firings and retir...

Lykos will certainly inquire FDA to reexamine its own selection adhering to turndown of MDMA therapy for trauma

.Adhering to a bad showing for Lykos Therapeutics' MDMA prospect for post-traumatic stress disorder ...

AN 2 one-halfs headcount, ceases period 3 test after records let down

.AN2 Rehabs is reconsidering its organization in response to poor midphase records, swearing to give...

Merck pays out $700M for bispecific, spying autoimmune position and chance to test Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand in advance to challenge Amgen in a blood cancer...